We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Dolutegravir/Lamivudine
Australian Public Assessment Report
Device/Product Name
Dovato
Active ingredients
Dolutegravir/Lamivudine
AusPAR Date
Published
Sponsor
Submission Number
PM-2018-04002-1-2
Submission Type
New combination of previously approved active ingredients
Decision
Approved